Lifestyle Change Implementation Research Network at PRC at UMass Chan

The goal of this project is to study how well the Noom digital lifestyle program works for adults who are taking Glucagon-Like Peptide-1 receptor agonist (GLP-1) medications. The study team will assess how the program affects people's behaviors and health outcomes. The team will also look at how digital lifestyle change interventions can be implemented in real-world settings, including how many people it reaches, how well it is put into practice, whether people stick with it over time, and whether it works well for different groups of people.

NCT Number	NCT07481305
Lead Sponsor	University of Massachusetts, Worcester Collaborators: University of Massachusetts, Lowell, Centers for Disease Control and Prevention
Conditions	GLP - 1
Enrollment	220 participants
Start Date	2026-07-22
Primary Completion	2029-04-30 (estimated)
Study Completion	2029-09-29 (estimated)
Updated on ClinicalTrials.gov	2026-07-28